Evidence map›Paper›PMID 27983490›Full record

ArticleEmerging infectious diseases2017

Increased Invasive Pneumococcal Disease, North East England, UK.

Catherine Houseman, Gareth J Hughes, Kaye E Chapman, Deborah Wilson, Russell Gorton

Abstract read
In one paragraph

Article in Emerging infectious diseases, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed.

  1. Invasive Pneumococcal Disease and Potential Impact of Pneumococcal Conjugate Vaccines Among Adults, Including Persons Experiencing Homelessness-Alaska, 2011-2020.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2024
    Article
  2. Parapneumonic effusions related toBMJ open respiratory research · 2023
    Article
  3. Emerging microbes & infections · 2021
    Observational
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Catherine Houseman
Gareth J Hughes
Kaye E Chapman
Deborah Wilson
Russell Gorton

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Since April 2014, invasive pneumococcal disease incidence has increased substantially across North East England, United Kingdom, reversing the decline that followed the 2006 introduction of pneumococcal conjugate vaccines. Significant increases occurred in 23-valent polysaccharide vaccine serotypes and nonvaccine serotypes. Trends in other regions and long-term effects of multivalent vaccines require further investigation.

Indexed as

AdolescentAdultAgedChildChild, PreschoolEpidemiological MonitoringFemaleHumansIncidenceInfantMaleMiddle AgedPneumococcal InfectionsPneumococcal VaccinesSerogroupStreptococcus pneumoniae23-valent pneumococcal capsular polysaccharide vaccinePneumococcal VaccinesbacteriaEnglandincidenceinvasive pneumococcal diseasePCV13 vaccinepneumococcal infectionspneumococcal polysaccharide vaccineStreptococcus pneumoniaeUnited Kingdomvaccines

Identifiers

PMID27983490
PMCPMC5176212

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.